gvtcx

NHS Framework Agreement for the supply of Human Albumin

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Statuscomplete
Category (CPV) 33141540
Procedureopen
OCIDocds-h6vhtk-02a4d6

Awards (5)

This procurement was awarded to 5 suppliers. Values shown are per-award; the notice total is ·.

SupplierValueDateStatus
Bio Products Laboratory Ltd shared · · active
Biotest UK Limited shared · · active
CSL Behring UK Ltd shared · · active
Grifols UK Ltd. shared · · active
Octapharma Limited shared · · active

description

NHA Framework Agreement for the supply of Human Albumin. The framework will commence on 1 May 2021 for a period of 18 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
12 Apr 2021 Contract award notice (F03) Earlier regulations 007525-2021

more from The NHS Commissioning Board (operating under the name of NHS England)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.